{"id":"https://openalex.org/W10195258","doi":null,"title":"Management of type 2 diabetes mellitus with special reference to metformin therapy.","display_name":"Management of type 2 diabetes mellitus with special reference to metformin therapy.","publication_year":1991,"publication_date":"1991-05-01","ids":{"openalex":"https://openalex.org/W10195258","mag":"10195258","pmid":"https://pubmed.ncbi.nlm.nih.gov/1936475"},"language":"en","primary_location":{"id":"pmid:1936475","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1936475","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabete & metabolisme","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110154985","display_name":"I W Campbell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134181","display_name":"Victoria Hospital","ror":"https://ror.org/02stzb903","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2803037235","https://openalex.org/I4210134181"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"I W Campbell","raw_affiliation_strings":["Diabetic Department, Victoria Hospital, Kirkcaldy, Fife, Scotland, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetic Department, Victoria Hospital, Kirkcaldy, Fife, Scotland, U.K","institution_ids":["https://openalex.org/I4210134181"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110154985"],"corresponding_institution_ids":["https://openalex.org/I4210134181"],"apc_list":null,"apc_paid":null,"fwci":0.8189,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.68175649,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"17","issue":"1 Pt 2","first_page":"191","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9769999980926514},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9919999837875366},{"id":"https://openalex.org/keywords/gliclazide","display_name":"gliclazide","score":0.8429999947547913},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7649999856948853},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.7160000205039978},{"id":"https://openalex.org/keywords/lactic-acidosis","display_name":"lactic acidosis","score":0.7260000109672546},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8009999990463257},{"id":"https://openalex.org/keywords/hyperinsulinemia","display_name":"hyperinsulinemia","score":0.9139999747276306},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5429999828338623},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.4580000042915344},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.9796115159988403},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8381558656692505},{"id":"https://openalex.org/C2777448766","wikidata":"https://www.wikidata.org/wiki/Q290001","display_name":"Gliclazide","level":3,"score":0.8306374549865723},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7935888767242432},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6968517303466797},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6927759647369385},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6002032160758972},{"id":"https://openalex.org/C2780317664","wikidata":"https://www.wikidata.org/wiki/Q1500373","display_name":"Lactic acidosis","level":2,"score":0.5729643106460571},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5554434657096863},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5309169888496399}],"mesh":[{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:1936475","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1936475","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabete & metabolisme","raw_type":"Comparative Study"},{"id":"mag:10195258","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1936475","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1831980957","https://openalex.org/W1968062717","https://openalex.org/W1911592439","https://openalex.org/W2167556067","https://openalex.org/W2071723829","https://openalex.org/W2075172416","https://openalex.org/W117543825","https://openalex.org/W2087600724","https://openalex.org/W1964423574","https://openalex.org/W2002328144"],"abstract_inverted_index":{"As":[0],"monotherapy,":[1],"metformin":[2,71,131],"is":[3,36,43,72,82],"similar":[4,134],"to":[5],"the":[6,22,57,79,105,126],"sulphonylureas,":[7,23],"in":[8,39,54,104,111,125],"improving":[9],"both":[10,86],"fasting":[11],"and":[12,29,35,53],"post-prandial":[13],"plasma":[14,145],"glucose":[15],"levels":[16,121],"by":[17],"approx.":[18],"25-30%.":[19],"Metformin,":[20],"unlike":[21],"does":[24,30,114],"not":[25,31,115],"promote":[26],"insulin":[27,117,120,146],"secretion":[28],"cause":[32],"weight":[33],"gain":[34],"therefore":[37],"preferable":[38],"obese":[40],"NIDDM.":[41],"Metformin":[42,98],"also":[44],"of":[45,88,107],"benefit":[46],"as":[47,62,66,137],"combined":[48],"therapy":[49],"with":[50,70,109,142],"a":[51,101,138],"sulphonylurea,":[52],"older":[55],"subjects":[56],"two":[58],"drugs":[59,89],"may":[60,99],"give":[61],"good":[63],"glycaemic":[64,135],"control":[65,136],"insulin.":[67],"Lactic":[68],"acidosis":[69],"less":[73],"common":[74],"than":[75],"sulphonylurea-induced":[76],"hypoglycaemia":[77],"although":[78],"mortality":[80],"risk":[81],"similar.":[83],"However,":[84],"where":[85],"groups":[87],"are":[90,96],"properly":[91],"used":[92],"clinically,":[93],"serious":[94],"side-effects":[95],"unusual.":[97],"have":[100,122],"potential":[102],"advantage":[103],"management":[106],"NIDDM":[108],"hyperinsulinaemia":[110],"that":[112],"it":[113],"increase":[116],"levels.":[118,147],"Where":[119],"been":[123],"compared":[124],"same":[127],"type":[128],"II":[129],"patients,":[130],"can":[132],"achieve":[133],"sulphonylurea":[139],"(gliclazide)":[140],"but":[141],"significantly":[143],"lower":[144]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}